Rang	Name	Position
1	Dr. Laurent Fischer M.D.	President, CEO & Director
2	Ms. Linda M. Rubinstein M.A.	CFO, Principal Financial Officer & Principal Accounting Officer
3	Mr. Kishor Peter Soparkar J.D.	Chief Operating Officer
4	Dr. Setareh Seyedkazemi Pharm.D.	Chief Development Officer
5	Dr. Rabia Gurses Ozden M.D.	Chief Medical Officer
6	Dr. R. Andrew Ramelmeier Ph.D.	Chief Technology Officer
7	Dr. Romuald Corbau Ph.D.	Chief Scientific Officer
8	Ms. Aneta Ferguson	General Counsel
9	Ms. Dena House	Chief People Officer
10	Ms. Carla Fiankan	Senior Vice President of Regulatory Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BML Capital Management LLC	14,57%	14,03 Mio. USD
2	TCG Crossover Management, LLC	8,56%	8,24 Mio. USD
3	Principia Wealth Advisory, LLC	8,09%	7,78 Mio. USD
4	Vanguard Group Inc	4,21%	4,06 Mio. USD
5	Renaissance Technologies Corp	2,72%	2,62 Mio. USD
6	5AM Venture Management, LLC	2,58%	2,49 Mio. USD
7	Goldman Sachs Group Inc	2,37%	2,28 Mio. USD
8	BlackRock Inc	1,98%	1,90 Mio. USD
9	Pale Fire Capital SE	1,71%	1,65 Mio. USD
10	Millennium Management LLC	1,63%	1,57 Mio. USD
11	Soleus Capital Management, L.P.	1,37%	1,32 Mio. USD
12	Dimensional Fund Advisors, Inc.	1,36%	1,31 Mio. USD
13	Geode Capital Management, LLC	0,88%	0,85 Mio. USD
14	Regeneron Pharmaceuticals Inc	0,86%	0,83 Mio. USD
15	Warren Averett Asset Management, LLC	0,77%	0,74 Mio. USD
16	Grant/GrossMendelsohn, LLC()	0,76%	0,74 Mio. USD
17	Citadel Advisors Llc	0,37%	0,36 Mio. USD
18	Jane Street Group LLC	0,34%	0,33 Mio. USD
19	State Street Corp	0,33%	0,32 Mio. USD
20	Readystate Asset Management LP	0,32%	0,31 Mio. USD